Voyager

VYGR NASDAQ
25.74
-1.99
-7.18%
盘前: 25.74 0 0.00% 08:08 06/25 EDT
开盘
27.61
昨收
27.73
最高
28.02
最低
25.70
成交量
48.06万
成交均量(3M)
46.26万
52周最高
28.79
52周最低
7.76
换手率
1.30%
市值
9.48亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Voyager VYGR股票价格,Voyager股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company. The Company focuses on developing treatments for patients suffering from severe diseases of the central nervous system (CNS). The Company's pipeline consists of programs for CNS indications, including advanced Parkinson's disease; a monogenic form of amyotrophic lateral sclerosis (ALS); Huntington's disease; Friedreich's ataxia; frontotemporal dementia/Alzheimer's disease, and severe chronic pain. The Company's clinical candidate, VY-AADC01, is an adeno-associated virus (AAV) gene therapy product candidate, for the treatment of advanced Parkinson's disease. VY-AADC01 consists of the AAV2 capsid, which has been used in multiple AAV gene therapy clinical trials for various diseases, and the cytomegalovirus promoter that drives expression of the aromatic L-amino acid decarboxylase (AADC) transgene. Its pipeline also includes VY-SOD101, VY-FXN01, VY-HTT01, VY-TAU01 and VY-NAV01.
展开 >

最近浏览

名称
价格
涨跌幅